English
Home > Products > CAS:28721-07-5

China CAS:28721-07-5 Manufacturer

We not only will try our greatest to offer superb companies to just about every buyer, but also are ready to receive any suggestion offered by our shoppers for CAS:28721-07-5, We are going to do our best to fulfill your specifications and are sincerely searching forward to building mutual valuable organization romantic relationship along with you!
CAS:28721-07-5, Welcome to visit our company and factory, there are various solutions displayed in our showroom that will meet your expectation, meanwhile, if you are convenient to visit our website, our sales staff will try their efforts to deliver you the best service

Related Products

Hot Products

  • Finasteride

    Finasteride

    Finasteride has EP, USP, CP, IP, JP specifications. CEP available, FDA, PMDA and GMP approved.

    CAS:98319-26-7

  • Desonide

    Desonide

    Desonide has USP and EP specifications. DMF available.

    CAS:638-94-8

  • DHEA (Prasterone)

    DHEA (Prasterone)

    DHEA (Prasterone) has FP and In-house specification. DMF and WC available.

    CAS:53-43-0

  • 17a-Hydroxyprogesterone

    17a-Hydroxyprogesterone

    17a-Hydroxyprogesterone is an endogenous progesteroid hormone similar to progesterone.

    CAS:68-96-2

  • Mifepristone Tablets 25mg*6

    Mifepristone Tablets 25mg*6

    Mifepristone Tablets 25mg*6
    Indications：Abortion
  • Epiandrosterone

    Epiandrosterone

    Epiandrosterone is a steroid hormone with weak androgenic activity. It is a metabolite of testosterone and dihydrotestosterone (DHT).

    CAS:481-29-8

  • Related Blog
  • Reviews

  • 2022 API Exhibition Qingdao

    August 2022
    Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
    Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
    99% manufactures meets the requirements of GMP.
    Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

  • 2022 CPhI Exhibition Shanghai

    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • CPHI & PMEC China 2024 Ended Successfully

    From June 19 to 21, the 22nd World Pharmaceutical Raw Materials China Exhibition (CPHI China 2024), organized by Informa Markets and China Chamber of Commerce for Import and Export of Pharmaceutical and Health Products and co-organized by Shanghai Bohua International Exhibition Co., LTD., was held in Shanghai. Nearly 3,500 well-known exhibitors at home and abroad gathered in Shanghai New International Expo Center (Pudong), attracting more than 60,000 professional buyers from more than 150 countries and regions, and a total of more than 90,000 industry colleagues to participate in the event.

  • 2025 Corporate Exhibition Calendar Officially Released !

    Our 2025 Exhibition Calendar has been announced! Come meet our team and explore new business opportunities.We look forward to seeing you there!

  • CPhI South East Asia 2025-See you at booth N33

    CPhI South East Asia 2025 will be held at MITEC, Kuala Lumpur, Malaysia from 16 Jul to 18 Jul 2025, our booth number is N33.

  • Why Is Intermediates Category So Important in Modern Pharmaceutical Manufacturing?

    When buyers search for an Intermediates Category supplier, they are rarely looking for a catalog page alone. They want consistency, traceability, dependable scale-up, and confidence that every stage before the final active ingredient has been handled with discipline.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept